Cargando…

Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial

BACKGROUND: Acute gastroenteritis is a major cause of pediatric morbidity and mortality, accounting for 15% of all childhood deaths worldwide. In developing countries, diarrheal diseases continue to be a major public health burden. Evidence from developed countries suggests that intake of lactose-fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabulsi, Mona, Yazbeck, Nadine, Charafeddine, Fatme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324790/
https://www.ncbi.nlm.nih.gov/pubmed/25771831
http://dx.doi.org/10.1186/s13063-015-0565-9
_version_ 1782356722606669824
author Nabulsi, Mona
Yazbeck, Nadine
Charafeddine, Fatme
author_facet Nabulsi, Mona
Yazbeck, Nadine
Charafeddine, Fatme
author_sort Nabulsi, Mona
collection PubMed
description BACKGROUND: Acute gastroenteritis is a major cause of pediatric morbidity and mortality, accounting for 15% of all childhood deaths worldwide. In developing countries, diarrheal diseases continue to be a major public health burden. Evidence from developed countries suggests that intake of lactose-free milk during diarrheal episodes may reduce the duration of the illness in pediatric inpatients. It is unknown whether lactose-free milk reduces the severity or duration of acute gastroenteritis in infants treated in outpatient settings in developing countries where diarrhea is more severe, and results in higher morbidities and mortalities. We hypothesize that lactose-free milk intake during acute gastroenteritis would significantly decrease the duration and severity of diarrhea in infants presenting to the Emergency Department (ED), as compared with lactose-containing milk. METHODS/DESIGN: An open-label randomized clinical trial. Study population: 40 infants with acute gastroenteritis, age between 2 and 12 months, presenting to the ED, will be randomized to control or intervention group. Intervention: Lactose-free milk, whereas the control group will continue on regular infant formula for a total of 7 days. Infants will be followed up for 7 days. Outcome measures: Diarrhea duration, weight loss, illness clinic visits, hospitalization rate, parental satisfaction, and time to symptom resolution. Statistical analysis: Descriptive and regression analysis will be conducted under the intention-to-treat basis by using SPSS version 21. DISCUSSION: Acute gastroenteritis is a public health burden for developing countries, with a significant impact on infant morbidity and mortality. Provision of infant formula that may reduce the duration and severity of diarrhea can decrease this burden in countries with limited healthcare resources, like Lebanon. The findings from this study are anticipated to provide evidence-based dietary recommendations for ambulatory infants with acute diarrhea in developing countries. TRIAL REGISTRATION: ClinicalTrials.gov NCT02246010; September 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0565-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4324790
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43247902015-02-12 Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial Nabulsi, Mona Yazbeck, Nadine Charafeddine, Fatme Trials Study Protocol BACKGROUND: Acute gastroenteritis is a major cause of pediatric morbidity and mortality, accounting for 15% of all childhood deaths worldwide. In developing countries, diarrheal diseases continue to be a major public health burden. Evidence from developed countries suggests that intake of lactose-free milk during diarrheal episodes may reduce the duration of the illness in pediatric inpatients. It is unknown whether lactose-free milk reduces the severity or duration of acute gastroenteritis in infants treated in outpatient settings in developing countries where diarrhea is more severe, and results in higher morbidities and mortalities. We hypothesize that lactose-free milk intake during acute gastroenteritis would significantly decrease the duration and severity of diarrhea in infants presenting to the Emergency Department (ED), as compared with lactose-containing milk. METHODS/DESIGN: An open-label randomized clinical trial. Study population: 40 infants with acute gastroenteritis, age between 2 and 12 months, presenting to the ED, will be randomized to control or intervention group. Intervention: Lactose-free milk, whereas the control group will continue on regular infant formula for a total of 7 days. Infants will be followed up for 7 days. Outcome measures: Diarrhea duration, weight loss, illness clinic visits, hospitalization rate, parental satisfaction, and time to symptom resolution. Statistical analysis: Descriptive and regression analysis will be conducted under the intention-to-treat basis by using SPSS version 21. DISCUSSION: Acute gastroenteritis is a public health burden for developing countries, with a significant impact on infant morbidity and mortality. Provision of infant formula that may reduce the duration and severity of diarrhea can decrease this burden in countries with limited healthcare resources, like Lebanon. The findings from this study are anticipated to provide evidence-based dietary recommendations for ambulatory infants with acute diarrhea in developing countries. TRIAL REGISTRATION: ClinicalTrials.gov NCT02246010; September 2014. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0565-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-08 /pmc/articles/PMC4324790/ /pubmed/25771831 http://dx.doi.org/10.1186/s13063-015-0565-9 Text en © Nabulsi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Nabulsi, Mona
Yazbeck, Nadine
Charafeddine, Fatme
Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title_full Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title_fullStr Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title_full_unstemmed Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title_short Lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
title_sort lactose-free milk for infants with acute gastroenteritis in a developing country: study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324790/
https://www.ncbi.nlm.nih.gov/pubmed/25771831
http://dx.doi.org/10.1186/s13063-015-0565-9
work_keys_str_mv AT nabulsimona lactosefreemilkforinfantswithacutegastroenteritisinadevelopingcountrystudyprotocolforarandomizedcontrolledtrial
AT yazbecknadine lactosefreemilkforinfantswithacutegastroenteritisinadevelopingcountrystudyprotocolforarandomizedcontrolledtrial
AT charafeddinefatme lactosefreemilkforinfantswithacutegastroenteritisinadevelopingcountrystudyprotocolforarandomizedcontrolledtrial